Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of anti-inflammatory and antiviral compounds. Its structure allows for effective conjugation in drug design, enhancing metabolic stability and bioavailability. Commonly employed in research settings for creating analogs in medicinal chemistry programs targeting enzyme inhibition. Also utilized in the preparation of fluorinated organic molecules where the difluoromethoxy group contributes to improved lipophilicity and binding affinity.